[mo_oauth_login]
Summary report
MEDISFÄÄR AS
Date of report 02.05.2025
MEDISFÄÄR AS
10256841 -
Registered
Founded in
28.08.1997
Fixed capital
25,600 €
keywords
- eriarstiabi
MEDISFÄÄR AS
Scores and ratings
Reputation score
3400
What is Reputation score?
Credit Score
Trustworthy
0.01
Credit score today
Trustworthy
0.01
2016
year
Open the reports you want to print
Employees and salaries
MEDISFÄÄR AS
Number of employees and estimated average salaries?
| 2024 II | 2024 III | 2024 IV | 2025 I | |
| Number of employees | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
MEDISFÄÄR AS
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
| 2019 I | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... |
| 2015 IV | ...... | ...... | ...... | ...... |
| 2015 III | ...... | ...... | ...... | ...... |
| 2015 II | ...... | ...... | ...... | ...... |
| 2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
MEDISFÄÄR AS
Decision-makers?
Former decision-makers
Relations:
2
Turnover 2025:
1 606 763 €
Employees:
37
Anastassia Berngardt
★★★★
......
Credit Score: Trustworthy
Reputation score: 3570
Date of birth: ......
Active relations 2
7 followers
Relations:
9
Turnover 2025:
16 359 984 €
Employees:
104
Anatoli Belov
★★★★
......
Credit Score: Trustworthy
Reputation score: 17560
Date of birth: ......
Active relations 9
31 followers
*Every member of the management board may represent the public limited company in concluding all transactions.
MEDISFÄÄR AS
Former decision-makers?
Relations:
Turnover:
Employees:
Klara Sedaševa
★★★★
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
0 followers
Relations:
Turnover:
Employees:
Vladislav Seleznjov
★★★★
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
0 followers
Relations:
Turnover:
Employees:
Veera Seleznjova
★★★★
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
2 followers
Relations:
Turnover:
Employees:
Taisija Belova
★★★★
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
11 followers
MEDISFÄÄR AS
History of right of representation?
Field
Entertainment
Business age
27y
Beneficial country:
Estonia
Anatoli Belov
... - ...
Anastassia Berngardt
... - ...
Taisija Belova
... - ...
Veera Seleznjova
... - ...
Vladislav Seleznjov
... - ...
Klara Sedaševa
... - ...
1997
2001
2005
2009
2013
2017
2021
2025
1997
2000
2002
2005
2007
2010
2012
2015
2017
2020
2022
2025
MEDISFÄÄR AS
Owners?
Former owners
MEDISFÄÄR AS
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... |
Beneficiaries
Volumes and values of beneficiaries' assets
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Finances and assets
MEDISFÄÄR AS
Goodwill| EUR | 2023 | 2024 | 2025 | Trend |
| Goodwill | ...... | ...... | ...... | |
| Goodwill | ...... | ...... | ...... |
MEDISFÄÄR AS
Taxes paid and estimated average salaries| 2022 | 2023 | 2024 | 2025 | |
| National taxes | ...... | ...... | ...... | ...... |
| Labor taxes | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
MEDISFÄÄR AS
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2025 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
MEDISFÄÄR AS
Sales revenue by business arearevenue
| Field of activity | EMTAK code | Sales revenue (2023) | Sales revenue % |
| Provision of specialist care | 86221 | 815 471 € | 59,99 |
| Dentistry | - | - | |
| Dental provision | 86231 | 543 877 € | 40,01 |
MEDISFÄÄR AS
Sales revenue by country| Turnover EUR | 2023 | 2024 prognosis | 2025 prognosis | Trend |
| Total sales | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Total exports | ...... | ...... | ...... |
MEDISFÄÄR AS
Financial indicators and prognosis| Financial indicators | 2023 | 2024 Prognosis | 2025 Prognosis |
Trend |
| TURNOVER | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Other countries | ...... | ...... | ...... | |
| INTEREST INCOME | ...... | ...... | ...... | |
| OTHER BUSINESS INCOME | ...... | ...... | ...... | |
| TURNOVER IN RELATED COMPANY | ...... | ...... | ...... | |
| AVERAGE MONTHLY TURNOVER | ...... | ...... | ...... | |
| Available credit (credit limit) | ...... | ...... | ...... | |
| Settlement dates | ...... | ...... | ...... | |
| RECEIVED GRANTS € | ...... | ...... | ...... | |
| TENDERS WON € | ...... | ...... | ...... | |
| ASSETS | ...... | ...... | ...... | |
| Current assets | ...... | ...... | ...... | |
| Fixed assets | ...... | ...... | ...... | |
| LIABILITIES | ...... | ...... | ...... | |
| Short-term liabilities | ...... | ...... | ...... | |
| Long-term liabilities | ...... | ...... | ...... | |
| EQUITY | ...... | ...... | ...... | |
| Share-(equity capital) | ...... | ...... | ...... | |
| Retained profits | ...... | ...... | ...... | |
| Net profit | ...... | ...... | ...... | |
| NET WORKING CAPITAL | ...... | ...... | ...... | |
| NUMBER OF EMPLOYEES | ...... | ...... | ...... |
MEDISFÄÄR AS
Financial raiting: "VERY GOOD" (2025 prognosis)| Multipliers and income levels | 2024 prognosis | 2025 prognosis |
Trend |
| LIQUIDITY | ...... | ...... | |
| Net Working capital | ...... | ...... | |
| Short-term debt coverage ratio (X) | ...... | ...... | |
| EFFECTIVENESS | ...... | ...... | |
| Debt to assets ratio (X) | ...... | ...... | |
| Capitalisation multiplier (X) | ...... | ...... | |
| USE OF LOAN CAPITAL | ...... | ...... | |
| Turnover ratio of fixed assets (X) | ...... | ...... | |
| PROFITABILITY | ...... | ...... | |
| Sales revenues (%) | ...... | ...... | |
| Total asset revenues (%) | ...... | ...... | |
| Equity revenues (%) | ...... | ...... |
2025 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
MEDISFÄÄR AS
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2023 | 01.01.2023–31.12.2023 | 30.05.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 09.06.2023 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 28.06.2022 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 25.05.2021 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 29.06.2020 | ...... |
| 2018 | 01.01.2018–31.12.2018 | 13.05.2019 | ...... |
| 2017 | 01.01.2017–31.12.2017 | 04.06.2018 | ...... |
| 2016 | 01.01.2016–31.12.2016 | 17.05.2017 | ...... |
| 2015 | 01.01.2015–31.12.2015 | 15.04.2016 | ...... |
| 2014 | 01.01.2014–31.12.2014 | 30.04.2015 | ...... |
| 2013 | 01.01.2013–31.12.2013 | 12.05.2014 | ...... |
| 2012 | 01.01.2012–31.12.2012 | 07.05.2013 | ...... |
| 2011 | 01.01.2011–31.12.2011 | 21.05.2012 | ...... |
| 2010 | 01.01.2010–31.12.2010 | 23.05.2011 | ...... |
| 2009 | 01.01.2009–31.12.2009 | 28.05.2010 | ...... |
| 2008 | 01.01.2008–31.12.2008 | 09.06.2009 | ...... |
| 2007 | 01.01.2007–31.12.2007 | 19.05.2008 | ...... |
| 2006 | 01.01.2006–31.12.2006 | 27.06.2007 | ...... |
| 2005 | 01.01.2005–31.12.2005 | 29.06.2006 | ...... |
| 2004 | 01.01.2004–31.12.2004 | 30.06.2005 | ...... |
| 2003 | 01.01.2003–31.12.2003 | 30.06.2004 | ...... |
| 2002 | 01.01.2002–31.12.2002 | 02.07.2003 | ...... |
| 2001 | 01.01.2001–31.12.2001 | 28.06.2002 | ...... |
| 2000 | 01.01.2000–31.12.2000 | 27.06.2001 | ...... |
Liabilities and debts
MEDISFÄÄR AS
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
MEDISFÄÄR AS
Reports and assets-liabilities overview 02.05.2025?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
MEDISFÄÄR AS
Claims history?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
MEDISFÄÄR AS
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2025 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
MEDISFÄÄR AS
Bailiff's enforcement proceedings as of 02.05.2025?
Bailiff's enforcement proceedings MISSING
MEDISFÄÄR AS
Regulations of the Payment Order Department as of 02.05.2025?
Regulations of the Payment Order Department MISSING
MEDISFÄÄR AS
Court orders in the register as of 02.05.2025?
Court order MISSING
MEDISFÄÄR AS
Decisions of the Consumer Disputes Committee as of 02.05.2025?
Consumer disputes MISSING
MEDISFÄÄR AS
Court hearings as of 02.05.2025?
Court hearings MISSING
MEDISFÄÄR AS
Rulings as of 02.05.2025?
Court settlemets MISSING
MEDISFÄÄR AS
Notices and announcements as of 02.05.2025?
Announcements MISSING
Marketing
Business network
MEDISFÄÄR AS
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
MEDISFÄÄR AS
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.